Please use this identifier to cite or link to this item: http://ahro.austin.org.au/austinjspui/handle/1/9862
Title: Low-level vancomycin resistance in Staphylococcus aureus--an Australian perspective.
Authors: Howden, Benjamin P;Ward, P B;Johnson, Paul D R;Charles, Patrick G P;Grayson, M Lindsay
Affiliation: Infectious Diseases Department, Austin Health, Melbourne, Australia. benjamin.howden@austin.org.au
Issue Date: 1-Feb-2005
Citation: European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology; 24(2): 100-8
Abstract: Low-level vancomycin resistance in Staphylococcus aureus has emerged as a clinical problem over the past 8 years. The clinical relevance of this resistance has been questioned, and laboratory detection remains difficult and time consuming. There is, however, increasing evidence linking low-level vancomycin resistance with glycopeptide treatment failure in serious Staphylococcus aureus infections. Diagnostic laboratories and clinicians need to be aware of this resistance phenotype, to have procedures in place to detect the resistance, and to have strategies for managing patients with infections caused by resistant strains.
Internal ID Number: 15682283
URI: http://ahro.austin.org.au/austinjspui/handle/1/9862
DOI: 10.1007/s10096-004-1261-y
URL: http://www.ncbi.nlm.nih.gov/pubmed/15682283
Type: Journal Article
Subjects: Aged
Aged, 80 and over
Anti-Bacterial Agents.pharmacology
Australia
Humans
Male
Methicillin Resistance
Microbial Sensitivity Tests
Staphylococcal Infections.drug therapy.microbiology
Staphylococcus aureus.drug effects
Vancomycin Resistance
Appears in Collections:Journal articles

Files in This Item:
File SizeFormat 
15682283.pdf56.6 kBAdobe PDFView/Open


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.